Spanish drugmaker Grifols SA paid a higher price to buy blood plasma from an entity linked to its controlling family than from third-party suppliers, according to a regulator’s findings submitted in a ...

Grifols (GRFS) secures a win in its defamation lawsuit against Gotham City Research in the U.S. Read more here.

MADRID (Reuters) -A New York court has found enough evidence to proceed with a defamation lawsuit filed by Grifols against short seller Gotham City Research, though it dismissed many of the Spanish ...

Grifols lost more than 30 per cent of its market value last year, when Gotham City Research, a short-seller fund, released multiple reports accusing Grifols of overstating earnings and ...

Canadian investment fund Brookfield said Wednesday it has dropped its bid for Spanish pharmaceutical firm Grifols following disagreement over its valuation.

Grifols SA said on Tuesday that Canadian investment fund Brookfield Corp.’s BN-T potential €6.45-billion ($9.5-billion) offer significantly undervalued the Spanish drugmaker’s prospects and ...

Grifols' founding family and Canadian fund Brookfield are considering a joint takeover bid of the Spanish drugmaker to take it private, after the company shed billions in market value following a ...

Grifols has failed to quell investor doubts since Gotham’s move, even though it has removed members of the founding family from executive roles and appointed a new chief executive, Nacho Abia ...

Grifols' market value has shed billions of euros since short-sheller Gotham City Research released three reports in early January accusing the company of overstating earnings and understating debt ...